The primary objective of this clinical trial is to evaluate the safety and effectiveness of the 2,910 nm mid-infrared erbium-doped fluoride fiber glass laser (UltraClear, Acclaro Medical) for non-invasive dermatological aesthetic treatment of three facial regions: eyebrow lift (Region 1), submental tissue lift (Region 2), and improvement of rhytids and skin laxity in the cheeks, midface, and jawline (Region 3).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Objective measurement of maximal eyebrow lift according to quantitative 2D imaging.
Timeframe: Six months following final treatment
Blinded Photographic Review
Timeframe: Six months following final treatment
â—‹ Objective measurement of lax submental tissue lift according to quantitative 2D imaging.
Timeframe: Six months following final treatment